Inventor · disambiguated record
Mark Tornetta
Also filed as: TORNETTA MARK · TORNETTA MARK A · TORNETTA MARK ANTHONY
12 granted patents·9 pending applications·1,185 citations·filing 1986–2024
92Inventor score
Files withJANSSEN BIOTECH INC6DELVECCHIO ALFRED2JANSSEN PHARMACEUTICA NV2REALPRO LTD2TAVOTEK BIOTHERAPEUTICS HONG KONG LTD2
Top patents by PatentIndex Score
21 records- 0197US5032989AReal estate search and location system and methodREALPRO LTD·Filed 1989·Granted Jul 16, 1991·826 cites·12 claims
- 0292US10562968B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 18, 2020·18 cites·19 claims
- 0392US9090694B2ST2L antibody antagonistsJANSSEN BIOTECH INC·Filed 2013·Granted Jul 28, 2015·19 cites·4 claims
- 0490US9212227B2ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditionsJANSSEN BIOTECH INC·Filed 2013·Granted Dec 15, 2015·13 cites·15 claims
- 0589US11884722B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Granted Jan 30, 2024·1 cites·25 claims
- 0684US9951137B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2015·Granted Apr 24, 2018·4 cites·6 claims
- 0783US4870576AReal estate search and location system and methodREALPRO LTD·Filed 1986·Granted Sep 26, 1989·295 cites·4 claims
- 0881US11685777B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jun 27, 2023·1 cites·9 claims
- 0978US8785605B2Humanized IL-25 antibodiesALMAGRO JUAN CARLOS·Filed 2011·Granted Jul 22, 2014·5 cites·13 claims
- 1078US2024343796A1Anti- gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1176US10450377B2ST2L antagonists and methods of useJANSSEN BIOTECH INC·Filed 2018·Granted Oct 22, 2019·1 cites·18 claims
- 1268US2025215616A1Variable heavy chain only libraries, methods of preparation thereof, and uses thereofTAVOTEK BIOTHERAPEUTICS HONG KONG LTD·Filed 2024·Application pending·0 cites
- 1367US9062305B2Generation of human de novo pIX phage display librariesTSUI PING·Filed 2009·Granted Jun 23, 2015·2 cites·1 claims
- 1459US12024796B2Variable heavy chain only libraries, methods of preparation thereof, and uses thereofTAVOTEK BIOTHERAPEUTICS HONG KONG LTD·Filed 2021·Granted Jul 2, 2024·0 cites·31 claims
- 1555US2025277051A1Anti-cd38 antibodies, anti-cd3 antibodies, and bispecific antibodies, and uses thereofHANGZHOU UNOGEN BIOTECH LTD·Filed 2022·Application pending·0 cites
- 1654US2025270314A1Anti-cdh17 monoclonal and bispecific antibodies and uses thereofTAVOTEK BIOTECH SUZHOU LTD·Filed 2022·Application pending·0 cites
- 1751US2004171117A1Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disordersSMITHKLINE BEECHAM CORP·Filed 2003·Application pending·0 cites
- 1847US2004213788A1Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disordersFiled 2002·Application pending·0 cites
- 1945US2003211106A1Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disordersFiled 2001·Application pending·0 cites
- 2044US2006159695A1Anti-respiratory syncytial virus antibodies, antigens and uses thereofDELVECCHIO ALFRED·Filed 2005·Application pending·0 cites
- 2138US2011027294A1Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses ThereofDELVECCHIO ALFRED·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Tornetta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →